May 4

Mark Mofid’s plastic surgery practice in San Diego

Mark Mofid is a certified plastic surgeon who is based in La Jolla, San Diego. He attended Harvard University where he received his undergraduate degree in medicine. In his medical degree, he trained in general surgery and plastic surgery. He later joined Johns Hopkins university school of medicine where he studied an advanced craniofacial research fellowship. Currently, he is a staff surgeon at Scripps Memorial Hospital, Sharp Chula Vista medical center both of which are located in La Jolla area of San Diego. He is also among the members of clinical faculty of the University of California. He is a fellow in the American college of surgeons and sits in the American board of plastic surgery.

Mark Mofid owns an accredited clinic, surgery center and also provides laser services. The clinic is located in LA Jolla, San Diego county. The office has 3 specialists; a nurse, a dermatologist who happens to be his wife and himself a plastic surgeon. The clinic offers medical services, dermatological services, cosmetics and plastic surgery. According to Mark Mofid, the process of hiring new employees is rigorous. To him, experience doesn’t matter. He considers employees who are willing to commit a few years to learning everything about the field of surgery and dermatology. Later, helps these employees to find great career paths in the industry.

Mark Mofid believes in working together in serving the patients. He acknowledges that no one can satisfy the needs of all patients alone. This is why he has established referral relationship with another laser facility within the community which provides the laser needs that he cannot offer. In addition, he believes that good work is the best form of advertising. Doing good work is inexpensive and allows one to compete on quality rather than price. He doesn’t use any print advertising although he owns a website. Mark Mofid advice’s employers to do a thorough investigation on new employees, because some of them may land an organization in problems, additionally, startups should not be concerned about where they start, rather, they should work towards good services.


January 5

For The Latest and Most Thorough Oncology Research Go To Oncotarget

Oncotarget is a multidisciplinary journal that is published weekly supporting the submission of articles and research papers in the oncology and related fields. Since 2010, the platform has made information widely available to peers in the oncology field with the emphasis on a thoughtful presentation and quantification of the most recent and innovative thinking in this field of endeavor.

Other fields that relate to oncology are permissible topics which are allowed to be submitted. Subjects such as Cardiology, Pharmacology, Immunology/Microbiology, Endocrinology, Gerotarget/Aging, Neuropathology/Neuroscience, Metabolism, and Cell and Mol Biology can be included.

Articles are submitted to the Editorial Board of Oncotarget where they are evaluated and examined. The emphasis is on the merit of the thesis that is being presented, adequation citations and proofs, that give credibility to the presentation, uniqueness of the subject matter so that the article is simply not a regurgitation of previous research and a strong conclusion as to the use of the presented material.

Authors may be asked to submit raw data as part of the review process, and they should be ready to make such data available in the public arena in an accessible manner. The data and content must be purely original, and not be the work or research of past results.

All submitted material is subject to a peer review where two or more reviewers are assigned to the article. The editors on YouTube who perform the reviews are required to be experts in the field that is being pursued in the article. This affirms that those who pass judgment on the material will be those who know what they are about in all areas.

Opinion, religious inference, political leanings, slander, racial or gender innuendos and similar distractions are not permissible. The focus needs to be solely on the research subject at hand and nothing else. Any distraction takes away the purpose of the topic on being studied and takes away the validity of any conclusions rendered.

Editors are prohibited from utilizing any of the material which they are reviewing from using any of that material for their personal use. The peer to peer reviewing process along with the prohibition of the editor’s personal use of content ensures that the articles and research are pure throughout the process.

Learn more about Oncotarget: